PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
PRF Technologies Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$0.71−0.07 (-8.88%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
PRF Technologies Ltd. revenue by segment
By business segment
| Revenue | FY2025 | % of revenue |
|---|---|---|
| Solar [Member] | $17.00K | 100.0% |
| Clinical Development [Member] | $0 | 0.0% |
By product or service
By region
From the segment and revenue-disaggregation notes of PRF Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.